ST. LOUIS, July 28, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it has received ...
Stereotaxis STXS recently announced the regulatory submissions for the MAGiC catheter, which is seeking marketing clearance in Europe and the United States.These submissions follow successful initial ...
ST. LOUIS, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it received ...
ST. LOUIS, July 01, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the ...
Stereotaxis STXS recently announced the publication of initial clinical results from its MAGiC catheter in the Journal of Interventional Cardiac Electrophysiology. The study, titled “First In-Human ...
Stereotaxis STXS, a global leader in surgical robotics for minimally invasive endovascular intervention, recently announced the successful completion of the first U.S. commercial procedures using its ...
Stereotaxis’ MAGiC catheter is a robotically-navigated magnetic ablation catheter designed to perform cardiac ablation procedures that treat heart arrhythmia. The MAGiC catheter was developed based on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback